International Journal of Clinical Obstetrics and Gynaecology
2021, Vol. 5, Issue 5, Part C
Study of efficacy and compliance of iron sucrose in iron deficiency anaemia in pregnancy
Author(s): Dr. Rohini Kondrakunta
Abstract: A prospective study conducted at Apollo Medical College & Hospital to study the intravenous iron sucrose efficacy in moderate iron deficiency anemia in pregnancy in patients between 14-34 weeks of gestational age.100 patients with moderate iron deficiency anemia with hemoglobin between 7 -10 gm/dl and serum ferritin less than 15mg/ltand peripheral blood picture showing microcytic hypochromic anemia were included in the current study. Majority patients were multiparous with a mean age of 22.9 years and gestational period of 30-34weeks. 60% were vegetarians and 40% non -vegetarians in the present study. Out of100 patients, 70% were from rural area whereas 30% were from urban area. In the present study the mean change of pre-treatment and post- treatment heamoglobin level is found to be 1.6460 which is statistically significant. The median of pre-treatment and post treatment serum ferritin level is found to be 132.2680 which is statistically significant. Largely Iron sucrose can be a treatment of choice with no serious side effects and is indicated for correction of anemia in pregnancy or restoring maternal iron stores. Hence intravenous iron sucrose treatment will certainly help to reduce risk of homologous blood transfusions and correction of anemia.